Abdominal pain in adults with cystic fibrosis

European Journal of Gastroenterology and Hepatology

Volumn 26, Issue 2, 2014, Pages 129-136

  Nash, Edward F ^a   Ohri, Chandra M ^b   Stephenson, Anne L ^c   Durie, Peter R ^d  

^a UNIVERSITY HOSPITALS BIRMINGHAM NHS FOUNDATION TRUST   (United Kingdom)

^b GLENFIELD HOSPITAL   (United Kingdom)

^c ST MICHAEL'S HOSPITAL   (Canada)

^d HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Abdominal pain; Cystic fibrosis; Etiology; Imaging; Management

Indexed keywords

ACETYLCYSTEINE; AMIKACIN; ANTIBIOTIC AGENT; CEFTAZIDIME; CIPROFLOXACIN; DIATRIZOATE; DOCUSATE SODIUM; ENEMA; MACROGOL; METRONIDAZOLE; PROBIOTIC AGENT;

ABDOMINAL PAIN; ACUTE PANCREATITIS; ADENOCARCINOMA; ADULT DISEASE; APPENDIX DISEASE; ARTICLE; CHOLELITHIASIS; CHRONIC PANCREATITIS; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONSTIPATION; CYSTIC FIBROSIS; DIFFERENTIAL DIAGNOSIS; DIGESTIVE SYSTEM CANCER; DRUG MEGADOSE; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; FLUID RESUSCITATION; HUMAN; ILEUM CANCER; INTESTINE OBSTRUCTION; INTUSSUSCEPTION; LAPAROTOMY; MULTIPLE CYCLE TREATMENT; NEPHROLITHIASIS; NONHUMAN; PRIORITY JOURNAL; RISK FACTOR; SENNA; SMALL INTESTINAL BACTERIAL OVERGROWTH; SMALL INTESTINE DISEASE; ULTRASOUND; ADULT; ANIMAL; COMPLICATION; DIGESTIVE SYSTEM DISEASES; KIDNEY CALCULI; PAIN MEASUREMENT; PREDICTIVE VALUE; PROGNOSIS;

ABDOMINAL PAIN; ADULT; ANIMALS; CYSTIC FIBROSIS; DIAGNOSIS, DIFFERENTIAL; DIGESTIVE SYSTEM DISEASES; HUMANS; KIDNEY CALCULI; PAIN MEASUREMENT; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RISK FACTORS;

EID: 84891885192     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0000000000000011     Document Type: Article

References (52)

1. Littlewood JM. Abdominal pain in cystic fibrosis. J R Soc Med 1995; 88 (Suppl 25):9-17
2. Cystic Fibrosis Trust. Cystic Fibrosis Trust registry annual data report, 2010. Bromley, UK: Cystic Fibrosis Trust 2010; Available at: https:// www.cysticfibrosis.org.uk/media/181982/Registry-review-A4-v6.pdf
3. Dodge JA, Lewis PA, Stanton M, Wilsher J. Cystic fibrosis mortality and survival in the UK: 1947-2003. Eur Respir J 2007; 29:522-526 (Pubitemid 46372100)
4. Nash EF, Stephenson A, Helm EJ, Ho T, Thippanna CM, Ali A, et al. Intussusception in adults with cystic fibrosis: a case series with review of the literature. Dig Dis Sci 2011; 56:3695-3700
5. Alexander CL, Urbanski SJ, Hilsden R, Rabin H, MacNaughton WK, Beck PL. The risk of gastrointestinal malignancies in cystic fibrosis: case report of a patient with a near obstructing villous adenoma found on colon cancer screening and Barrett's esophagus. J Cyst Fibros 2008; 7:1-6
6. Littlewood JM,Wolfe SP, Conway SP. Diagnosis and treatment of intestinal malabsorption in cystic fibrosis. Pediatr Pulmonol 2006; 41:35-49 (Pubitemid 43117366)
7. Unsinn KM, Freund MC, Ellemunter H, Ladurner R, Koenigsrainer A, Gassner I, Jaschke WR. Spectrum of imaging findings after pediatric liver transplantation: part 2, posttransplantation complications. Am J Roentgenol 2003; 181:1139-1144 (Pubitemid 37151803)
8. Shitrit D, Shitrit AB, Dickman R, Sahar G, Saute M, Kramer MR. Gastrointestinal involvement of posttransplant lymphoproliferative disorder in lung transplant recipients: report of a case. Dis Colon Rectum 2005; 48:2144-2147 (Pubitemid 43035125)
9. Jensen KG. Meconium-ileus equivalent in a 15-year-old patient with mucoviscidosis. Acta Paediatr 1962; 51:344-348
10. Houwen RH, van der Doef HP, Sermet I, Munck A, Hauser B,Walkowiak J, et al. Defining DIOS and constipation in cystic fibrosis with a multicentre study on the incidence, characteristics, and treatment of DIOS. J Pediatr Gastroenterol Nutr 2010; 50:38-42
11. Gilljam M, Chaparro C, Tullis E, Chan C, Keshavjee S, Hutcheon M. GI complications after lung transplantation in patients with cystic fibrosis. Chest 2003; 123:37-41 (Pubitemid 36126711)
12. Morton JR, Ansari N, Glanville AR, Meagher AP, Lord RV. Distal intestinal obstruction syndrome (DIOS) in patients with cystic fibrosis after lung transplantation. J Gastrointest Surg 2009; 13:1448-1453
13. Andersen HO, Hjelt K,Waever E, Overgaard K. The age-related incidence of meconium ileus equivalent in a cystic fibrosis population: the impact of highenergy intake. J Pediatr Gastroenterol Nutr 1990; 11:356-360 (Pubitemid 20308962)
14. Sun L, Rommens JM, Corvol H, Li W, Li X, Chiang TA, et al. Multiple apical plasma membrane constituents are associated with susceptibility to meconium ileus in individuals with cystic fibrosis. Nat Genet 2012; 44:562-569
15. Van der Doef HP, Kokke FT, van der Ent CK, Houwen RH. Intestinal obstruction syndromes in cystic fibrosis: meconium ileus, distal intestinal obstruction syndrome, and constipation. Curr Gastroenterol Rep 2011; 13:265-270
16. Shields MD, Levison H, Reisman JJ, Durie PR, Canny GJ. Appendicitis in cystic fibrosis. Arch Dis Child 1991; 66:307-310
17. Warshauer DM, JKT Lee. Adult intussusception detected at CT or MR imaging: clinical-imaging correlation. Radiology 1999; 212:853-860 (Pubitemid 29410993)
18. Wilschanski M, Fisher D, Hadas-Halperin I, Picard E, Faber J, Goldberg S, et al. Findings on routine abdominal ultrasonography in cystic fibrosis patients. J Pediatr Gastroenterol Nutr 1999; 28:182-185 (Pubitemid 29293684)
19. Lewindon PJ, Robb TA, Moore DJ, Davidson GP, Martin AJ. Bowel dysfunction in cystic fibrosis: importance of breath testing. J Paediatr Child Health 1998; 34:79-82 (Pubitemid 28158512)
20. O'Brien S, Mulcahy H, Fenlon H, O'Broin A, Casey M, Burke A, et al. Intestinal bile acid malabsorption in cystic fibrosis. Gut 1993; 34:1137-1141 (Pubitemid 23245371)
21. Fridge JL, Conrad C, Gerson L, Castillo RO, Cox K. Risk factors for small bowel bacterial overgrowth in cystic fibrosis. J Pediatr Gastroenterol Nutr 2007; 44:212-218 (Pubitemid 46175075)
22. Schneider AR, Klueber S, Posselt H-G, Funk B, Murzynski L, Caspary WF, Stein J. Application of the glucose hydrogen breath test for the detection of bacterial overgrowth in patients with cystic fibrosis - a reliable method? Dig Dis Sci 2009; 54:1730-1735
23. De Lisle RC, Roach EA, Norkina O. Eradication of small intestinal bacterial overgrowth in the cystic fibrosis mouse reduces mucus accumulation. J Pediatr Gastroenterol Nutr 2006; 42:46-52 (Pubitemid 43061009)
24. Lisowska A, Pogorzelski A, Oracz G, Siuda K, Skorupa W, Rachel M, et al. Oral antibiotic therapy improves fat absorption in cystic fibrosis patients with small intestine bacterial overgrowth. J Cyst Fibros 2011; 10:418-421
25. Infante Pina D, Redecillas Ferreiro S, Torrent Vernetta A, Segarra Canton O, Maldonado Smith M, Gartner Tizziano L, Hidalgo Albert E. Improvement of intestinal function in cystic fibrosis patients using probiotics. An Pediatr (Barc) 2008; 69:501-505
26. Sheldon CD, Hodson ME, Carpenter LM, Swerdlow AJ. A cohort study of cystic fibrosis and malignancy. Br J Cancer 1993; 68:1025-1028 (Pubitemid 23315243)
27. Neglia JP, Fitzsimmons SC, Maisonneuve P, Schöni MH, Schöni-Affolter F, Corey M, Lowenfels AB. The risk of cancer among patients with cystic fibrosis. Cystic Fibrosis and Cancer Study Group. N Engl J Med 1995; 332:494-499
28. Maisonneuve P, Fitzsimmons SC, Negliz JP, Campbell PW, Lowenfels JP. Cancer risk in nontransplanted and transplanted cystic fibrosis patients: a 10-year study. J Natl Cancer Inst 2003; 95:381-387 (Pubitemid 36395258)
29. Wilschanski M, Durie PR. Patterns of GI disease in adulthood associated with mutations in the CFTR gene. Gut 2007; 56:1153-1163 (Pubitemid 47123248)
30. Bishop MD, Freedman SD, Zielenski J, Ahmed N, Dupuis A, Martin S, et al. The cystic fibrosis transmembrane conductance regulator gene and ion channel function in patients with idiopathic pancreatitis. Hum Genet 2005; 118:372-381 (Pubitemid 43091209)
31. Durno C, Corey M, Zielenski J, Tullis E, Tsui LC, Durie P. Genotype and phenotype correlations in patients with cystic fibrosis and pancreatitis. Gastroenterology 2002; 123:1857-1864 (Pubitemid 35408310)
32. Ooi CY, Dorfman R, Cipolli M, Gonska T, Castellani C, Keenan K, et al. Type of CFTR mutation determines risk of pancreatitis in patients with cystic fibrosis. Gastroenterology 2011; 140:153-161
33. Rovsing H, Sloth K. Micro-gallbladder and biliary calculi in mucoviscidosis. Acta Radiol Diagn (Stockh) 1973; 14:588-592
34. Modolell I, Alvarez A, Guarner L, De Gracia J, Malagelada JR. Gastrointestinal, liver, and pancreatic involvement in adult patients with cystic fibrosis. Pancreas 2001; 22:395-399 (Pubitemid 32402090)
35. Stern RC, Rothstein FC, Doershuk CF. Treatment and prognosis of symptomatic gallbladder disease in patients with cystic fibrosis. J Pediatr Gastroenterol Nutr 1986; 5:35-40 (Pubitemid 17006363)
36. Bahmanyar S, Ekbom A, Askling J, Johannesson M, Montgomery SM. Cystic fibrosis gene mutations and gastrointestinal diseases. J Cyst Fibros 2010; 9:288-291
37. Cystic Fibrosis Trust. UK CF registry annual report, 2009. Bromley, UK: Cystic Fibrosis Trust 2009; Available at: https://www.cysticfibrosis.org.uk/ media/82500/CR-Annual-Data-Report-2009-Mar-11.pdf
38. Henckaerts L, Jaspers M, Van Steenbergen W, Vliegen L, Fevery J, Nuytten H, et al. Cystic fibrosis transmembrane conductance regulator gene polymorphisms in patients with primary sclerosing cholangitis. J Hepatol 2009; 50:150-157
39. Salh B, Howat J,Webb K. Ursodeoxycholic acid dissolution of gallstones in cystic fibrosis. Thorax 1988; 43:490-491
40. Colombo C, Bertolini E, Assaisso ML, Bettinardi N, Glunta A, Podda M. Failure of ursodeoxycholic acid to dissolve radiolucent gallstones in patients with cystic fibrosis. Acta Paediatr 1993; 82:562-565 (Pubitemid 23188652)
41. Angelico M, Gandin C, Canuzzi P, Bertasi S, Cantafora A, De Santis A, et al. Gallstones in cystic fibrosis: a critical reappraisal. Hepatology 1991; 14:768-775
42. McGrath DS, Short C, Bredin CP, Kirwan WO, Rooney E, Meeke R. Laparoscopic cholecystectomy in adult cystic fibrosis. Ir J Med Sci 1997; 166:70-71 (Pubitemid 27216277)
43. Cogliandolo A, Patania M, Curro G, Chille G, Magazzu G, Navarra G. Postoperative outcomes and quality of life in patients with cystic fibrosis undergoing laparoscopic cholecystectomy: a retrospective study. Surg Laparosc Endosc Percutan Tech 2011; 21:179-183
44. Gibney EM, Goldfarb DS. The association of nephrocalcinosis with cystic fibrosis. Am J Kidney Dis 2003; 42:1-11
45. Hiatt RA, Dales LG, Friedman GD, Hunkeler EM. Frequency of urolithiasis in a prepaid medical care program. Am J Epidemiol 1982; 115:255-265 (Pubitemid 12182304)
46. Katz SM, Krueger JL, Falkner B. Microscopic nephrocalcinosis in cystic fibrosis. N Engl J Med 1988; 319:263-266
47. Chidekel AS, Dolan TF Jr. Cystic fibrosis and calcium oxalate nephrolithiasis. Yale J Biol Med 1996; 69:317-321 (Pubitemid 126687220)
48. Terribile M, Capuano M, Cangiano G, Carnovale V, Ferrara P, Petrarulo M, Marangella M. Factors increasing the risk for stone formation in adult patients with cystic fibrosis. Nephrol Dial Transplant 2006; 21:1870-1875 (Pubitemid 43985715)
49. Perez-Brayfield MR, Caplan D, Gatti JM, Smith EA, Kirsch AJ. Metabolic risk factors for stone formation in patients with cystic fibrosis. J Urol 2002; 167 (Pt 1):480-484 (Pubitemid 34074509)
50. Dharmsathaphorn K, Freeman DH, Binder HJ, Dobbins JW. Increased risk of nephrocalcinosis in patients with steatorrhoea. Dig Dis Sci 1982; 27:401-405 (Pubitemid 12161528)
51. Sidhu H, Hope B, Hesse A, Tenbrock K, Bromme S, Rietschel E, Peck AB. Absence of Oxalobacter formigenes in cystic fibrosis patients: a risk factor for hyperoxaluria. Lancet 1998; 352:1026-1029 (Pubitemid 28438575)
52. Stapleton FB, Kennedy J, Nousia-Arvanitakis S, Linshaw MA. Hyperuricosuria due to high-dose pancreatic extract therapy in cystic fibrosis. N Engl J Med 1976; 295:246-248.